Overview

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

Status:
RECRUITING
Trial end date:
2031-03-31
Target enrollment:
Participant gender:
Summary
This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Phase:
PHASE3
Details
Lead Sponsor:
SpyGlass Pharma, Inc.